United States · FDA National Drug Code directory
spironolactone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-691_3241a29b-82b9-fd3a-e063-6294a90aa46c
- Product NDC
- 31722-691
- Form
- SUSPENSION
- Composition / generic term
- spironolactone
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250221
- Source listing expiry
- 20261231
Source-listed ingredients
- SPIRONOLACTONE — 25 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 118 mL in 1 BOTTLE (31722-691-11) · 31722-691-11
- 473 mL in 1 BOTTLE (31722-691-47) · 31722-691-47
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →